Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.

Mejias J, Gonzalez-Barreto AR, Rodeghier M, DeBaun MR

Open source

DOI
10.1182/bloodadvances.2024013216
Published
2024 Nov 26
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2024013216,
  title = {Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.},
  author = {Mejias J and Gonzalez-Barreto AR and Rodeghier M and DeBaun MR},
  year = {2024},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2024013216},
  url = {https://doi.org/10.1182/bloodadvances.2024013216}
}

RIS

TY  - JOUR
TI  - Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.
AU  - Mejias J
AU  - Gonzalez-Barreto AR
AU  - Rodeghier M
AU  - DeBaun MR
PY  - 2024
JO  - Blood advances
DO  - 10.1182/bloodadvances.2024013216
UR  - https://doi.org/10.1182/bloodadvances.2024013216
ER  - 

APA

J, M., AR, G., M, R., & MR, D. (2024). Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial.. Blood advances. https://doi.org/10.1182/bloodadvances.2024013216

Source records